Lung & Respiratory Health News: FDA Approvals, IPF Trials & More

GSK’s Nucala earned FDA approval for eosinophilic COPD, becoming the first biologic for this broad subgroup. Liquidia’s YUTREPIA inhalation powder also received FDA approval for pulmonary hypertension, though legal issues may affect its launch. Health Canada is reviewing GSK’s Depemokimab, a potential first ultra-long-acting asthma biologic. ISAB partnered with BioLum to expand U.S. access to in vitro respiratory testing. Teva and Biolojic are advancing BD9, a novel asthma biologic. Tvardi and Rein Therapeutics progress Phase 2 trials targeting idiopathic pulmonary fibrosis.

Видео Lung & Respiratory Health News: FDA Approvals, IPF Trials & More канала LucidQuest